NCT06663787 2026-04-13
HER2 CR
Nagoya City University
Active not recruiting
Clinical Trials
6 trialsNCT04158258 2026-03-24
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
Hoffmann-La Roche
Active not recruiting
NCT05945927 2025-10-10
A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer
Hoffmann-La Roche
Completed
NCT05754502 2023-03-03
Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy
Consorzio Oncotech
Unknown
NCT04769050 2022-04-20
Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment
Fudan University
Unknown
NCT00833963 2019-05-16
MotHER
Genentech, Inc.
Completed